Top

Published in:

Open Access 01-03-2019 | Hypoxia • Original Article

The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea

Published in: Sleep and Breathing | Issue 1/2019

Abstract

Purpose

Growing evidence has revealed that nonalcoholic fatty liver disease (NAFLD) is associated with type 2 diabetes. This study aimed to assess the association between glycometabolism and NAFLD in patients with obstructive sleep apnea (OSA).

Methods

Patients with suspected OSA were enrolled consecutively and then underwent polysomnography, liver ultrasound, and biochemical measurements. Logistic regressions were used to identify factors associated with NAFLD.

Results

In total, 415 patients were included. The prevalence of NAFLD in the non-OSA, mild OSA, moderate OSA, and severe OSA groups was 37.21%, 69.09%, 68.34%, and 78.08%, respectively. Stepwise logistic regression suggested that percentage of total sleep time spent with oxygen saturation of < 90% (TS90), lowest oxygen saturation (LaSO₂), and homeostatic model assessment of insulin resistance (HOMA-IR) were independently associated with NAFLD in all subjects, after adjusting for confounders (odds ratio [OR] = 1.037, p = 0.014; OR = 1.056, p = 0.004; OR = 0.732, p = 0.009; respectively). TS90, LaSO₂, and HOMA-IR were also independent predictors for NAFLD in patients with mild and moderate OSA, whereas TS90, LaSO₂, and ODI were independent predictors for NAFLD in patients with severe OSA.

Conclusions

There is a relationship between OSA and NAFLD, and the combination of disordered glycometabolism and intermittent hypoxia may act as a “two hit” mechanism to promote the development of NAFLD. Furthermore, intermittent hypoxia alone was an independent predictor for NAFLD in severe OSA patients.

Seto W-K, Yuen M-F (2017) Nonalcoholic fatty liver disease in Asia: emerging perspectives. J Gastroenterol 52:164–174. https://doi.org/10.1007/s00535-016-1264-3 CrossRefPubMed

de Andrade GC, Fujise LH, de Santana JE, Oliveira F, de Silva RCMAD (2016) Non-alcoholic fatty liver disease (NAFLD) in different populations: a clinical and epidemiological study - sample of São José do Rio Preto. Rev Assoc Med Bras (1992) 62:218–226. https://doi.org/10.1590/1806-9282.62.03.218 CrossRef

Chon YE, Kim KJ, Jung KS, Kim SU, Park JY, Kim DY, Ahn SH, Chon CY, Chung JB, Park KH, Bae JC, Han KH (2016) The relationship between type 2 diabetes mellitus and non-alcoholic fatty liver disease measured by controlled attenuation parameter. Yonsei Med J 57:885–892. https://doi.org/10.3349/ymj.2016.57.4.885 CrossRefPubMedPubMedCentral

Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R (2016) The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology 64:1577–1586. https://doi.org/10.1002/hep.28785 CrossRefPubMed

Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845CrossRefPubMed

Gariani K, Philippe J, Jornayvaz FR (2013) Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab 39:16–26. https://doi.org/10.1016/j.diabet.2012.11.002 CrossRefPubMed

Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112. https://doi.org/10.1002/hep.20973 CrossRefPubMed

Eckel RH, Depner CM, Perreault L, Markwald RR, Smith MR, McHill AW et al (2015) Morning circadian misalignment during short sleep duration impacts insulin sensitivity. Curr Biol 25:3004–3010. https://doi.org/10.1016/j.cub.2015.10.011 CrossRefPubMed

Tanno S, Tanigawa T, Saito I, Nishida W, Maruyama K, Eguchi E, Sakurai S, Osawa H, Punjabi NM (2014) Sleep-related intermittent hypoxemia and glucose intolerance: a community-based study. Sleep Med 15:1212–1218. https://doi.org/10.1016/j.sleep.2014.05.027 CrossRefPubMed

10.

Jin S, Jiang S, Hu A (2018) Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Sleep Breath 64:1388–1311. https://doi.org/10.1007/s11325-018-1625-7 CrossRef

11.

Hang L-W, Chen C-F, Wang C-B, Wu T-N, Liang W-M, Chou T-C (2017) The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan. Sleep Breath 21:461–467. https://doi.org/10.1007/s11325-016-1439-4 CrossRefPubMed

12.

Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Ward SLD, Tangredi MM (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619. https://doi.org/10.5664/jcsm.2172 CrossRefPubMedPubMedCentral

13.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed

14.

Mehta S-R, Thomas E-L, Bell J-D, Johnston D-G, Taylor-Robinson S-D (2008) Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14:3476–3483. https://doi.org/10.3748/wjg.14.3476 CrossRefPubMedPubMedCentral

15.

Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090. https://doi.org/10.1002/hep.24452 CrossRefPubMed

16.

Musso G, Olivetti C, Cassader M, Gambino R (2012) Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms. Semin Liver Dis 32:49–64. https://doi.org/10.1055/s-0032-1306426 CrossRefPubMed

17.

Shpirer I, Copel L, Broide E, Elizur A (2010) Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung 188:301–307. https://doi.org/10.1007/s00408-009-9219-6 CrossRefPubMed

18.

Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J (2012) Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol 11:228–231CrossRefPubMed

19.

Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R (2013) Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev 14:417–431. https://doi.org/10.1111/obr.12020 CrossRefPubMed

20.

Türkay C, Ozol D, Kasapoğlu B, Kirbas I, Yıldırım Z, Yiğitoğlu R (2012) Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Respir Care 57:244–249. https://doi.org/10.4187/respcare.01184. CrossRefPubMed

21.

Corey KE, Misdraji J, Gelrud L, King LY, Zheng H, Malhotra A, Chung RT (2015) Obstructive sleep apnea is associated with nonalcoholic steatohepatitis and advanced liver histology. Dig Dis Sci 60:2523–2528. https://doi.org/10.1007/s10620-015-3650-8 CrossRefPubMedPubMedCentral

22.

Spahis S, Delvin E, Borys J-M, Levy E (2017) Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal 26:519–541. https://doi.org/10.1089/ars.2016.6776 CrossRefPubMed

23.

Parola M, Vajro P (2016) Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression. J Hepatol 65:470–472. https://doi.org/10.1016/j.jhep.2016.05.042 CrossRefPubMed

24.

Paschetta E, Belci P, Alisi A, Liccardo D, Cutrera R, Musso G, Nobili V (2015) OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. Mediat Inflamm 2015:815721–815710. https://doi.org/10.1155/2015/815721 CrossRef

25.

Lévy P, Bonsignore MR, Eckel J (2009) Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34:243–260. https://doi.org/10.1183/09031936.00166808 CrossRefPubMed

26.

Patinkin ZW, Feinn R, Santos M (2017) Metabolic consequences of obstructive sleep apnea in adolescents with obesity: a systematic literature review and meta-analysis. Child Obes 13:102–110. https://doi.org/10.1089/chi.2016.0248 CrossRefPubMed

27.

Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE, Sleep Heart Health Study Investigators (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol 160:521–530. https://doi.org/10.1093/aje/kwh261 CrossRefPubMed

28.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131. https://doi.org/10.1053/j.gastro.2010.09.038 CrossRefPubMed

29.

Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175:851–857. https://doi.org/10.1164/rccm.200610-1527OC CrossRefPubMedPubMedCentral

30.

Pamidi S, Wroblewski K, Stepien M, Sharif-Sidi K, Kilkus J, Whitmore H, Tasali E (2015) Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med 192:96–105. https://doi.org/10.1164/rccm.201408-1564OC CrossRefPubMedPubMedCentral

31.

Sookoian S, Pirola CJ (2013) Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Obes Surg 23:1815–1825. https://doi.org/10.1007/s11695-013-0981-4 CrossRefPubMed

32.

Lechin F, van der Dijs B (2006) Central nervous system circuitry involved in the hyperinsulinism syndrome. Neuroendocrinology 84:222–234. https://doi.org/10.1159/000098005 CrossRefPubMed

33.

Wang X, Yu Q, Yue H, Zeng S, Cui F (2015) Effect of intermittent hypoxia and rimonabant on glucose metabolism in rats: involvement of expression of GLUT4 in skeletal muscle. Med Sci Monit 21:3252–3260. https://doi.org/10.12659/MSM.896039 CrossRefPubMedPubMedCentral

34.

Gil-Lozano M, Hunter PM, Behan L-A, Gladanac B, Casper RF, Brubaker PL (2016) Short-term sleep deprivation with nocturnal light exposure alters time-dependent glucagon-like peptide-1 and insulin secretion in male volunteers. Am J Physiol Endocrinol Metab 310:E41–E50. https://doi.org/10.1152/ajpendo.00298.2015 CrossRefPubMed

35.

Qi J-C, Huang J-C, Lin Q-C, Zhao J-M, Lin X, Chen L-D, Huang JF, Chen X (2016) Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. Sleep Breath 20:529–535. https://doi.org/10.1007/s11325-015-1232-9 CrossRefPubMed

Title: The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea
Publication date: 01-03-2019
Published in: Sleep and Breathing / Issue 1/2019
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-018-1744-1

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Sleep phenotype in the Townes mouse model of sickle cell disease

Arousal index as a marker of carotid artery atherosclerosis in patients with obstructive sleep apnea syndrome

Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model

Impact of continuous positive airway pressure on vascular endothelial growth factor in patients with obstructive sleep apnea: a meta-analysis

Effects of continuous positive airway pressure on cardiovascular biomarkers in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials

Risk of gallstones in patients with obstructive sleep apnea: a nationwide observational cohort study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page